Value Bridge — ST. MARY MEDICAL CENTER
Current $-49M → Target $-41M (+$8.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-49.3M
Current EBITDA
$-40.8M
Target EBITDA
+$8.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.9M
Payer Mix Optimization
$4.7M
Cost to Collect Reduction
$1.6M
Clean Claim Improvement
$1.2M
Volume & Rate Growth
$7.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-49M to $-41M. The highest-impact lever is Volume & Rate Growth at $3.1M probability-weighted.
IC talking point: "We see $9M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $94M in equity value creation."